Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-09

Clinical Trial Update: The Effect of Sorafenib on Portal Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of sorafenib on portal pressure in clinically significant portal hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)

Snippet

Sponsor: Yale University | Conditions: Clinically Significant Portal Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09